Genflow Biosciences
Founded in 2020, Genflow Biosciences plc is an emerging leader in longevity research with R&D facilities in Belgium. The company develops novel therapeutic approaches potentially targeting the aging process in humans and dogs, with its lead compound GF-1002 delivering a centenarian variant of the SIRT6 gene identified in individuals aged 100 or beyond.
Key People
Eric Leire - Chief Executive Officer